The effect of continuous femoral nerve block on analgesia programme following total knee arthroplasty: a clinical study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002537

Enrollment

Unknown

Registered

2012-09-21

Start date

2012-01-02

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee arthritis

Interventions

three group:femoral nerve block

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adults (40–80 yr) scheduled to undergo primary, unilateral, tricompartment, cemented TKA via a 12- to 18-cm midline skin incision and parapatellar approach who desired a cFNB for postoperative analgesia.

Exclusion criteria

Exclusion criteria: A history of opioid dependence or current chronic analgesic therapy (daily use>4 weeks), allergy to study medications, known hepatic or renalinsufficiency/disease, peripheral neuropathy, morbid obesity (body mass index >40 kg/m2), pregnancy, incarceration,or comorbidity that resulted in moderate or severe functional limitation.

Design outcomes

Primary

Measure	Time frame
pain VAS;physical therapy;morphine consumption;time to attain three discharge criteri;	—

Secondary

Measure	Time frame
patient satisfaction;adverse reactions to anesthetic drugs;sleeping quality;	—

Countries

China

Contacts

Public ContactXuzhong Xu

xuzhong@263.net+86 13706657799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026